氢气通过调控血红素氧合酶-1和高迁移率族蛋白B1对严重脓毒症小鼠肠损伤发挥保护作用
该研究为动物实验,将280只雄性野生型(WT)和Nrf2敲除(Nrf2-KO)ICR小鼠随机分为8组(每组n=35),比较假手术组、氢气吸入组、盲肠结扎穿孔(CLP)脓毒症模型组及氢气治疗组的差异。结果显示,2%氢气吸入60分钟使WT脓毒症小鼠7天生存率从0%升至45%(P<0.05),并改善腹腔细菌清除(CFU ×10³:34.7±6.3 vs 74.2±8.1,P<0.01),上调HO-1、下调HMGB1表达;而在Nrf2-KO小鼠中上述效应均消失。结论提示氢气通过Nrf2/HO-1/HMGB1通路减轻严重脓毒症小鼠肠损伤。
要点
- 在WT严重脓毒症小鼠中,2%氢气吸入60分钟使7天生存率从0%提高至45%(P<0.05),Nrf2-KO小鼠无此获益。
- 氢气治疗提高WT小鼠腹腔细菌清除率(PLF CFU ×10³:34.7±6.3 vs 74.2±8.1,P<0.01),Nrf2-KO小鼠无显著变化。
- 氢气上调WT小鼠肠组织HO-1蛋白表达(HO-1/β-actin:0.716±0.035 vs 0.460±0.045,P<0.01),Nrf2-KO小鼠无差异。
- 氢气降低WT小鼠肠组织HMGB1蛋白表达(HMGB1/β-actin:0.052±0.038 vs 0.082±0.008,P<0.01),Nrf2-KO小鼠无差异。
- 该研究为小鼠实验,氢气吸入方案(2% H2、60分钟)为实验条件,尚不能直接转化为临床脓毒症患者的推荐治疗。
适用人群与场景
- 雄性野生型(WT)和Nrf2敲除(Nrf2-KO)ICR小鼠,6-8周龄,体重20-25 g。
- 严重脓毒症模型采用盲肠结扎穿孔(CLP)诱导。
- 实验场景为动物实验,非急诊或ICU临床人群。
诊断标准与关键阈值
- 严重脓毒症模型标准:盲肠结扎穿孔(CLP)诱导。
- Nrf2敲除小鼠用于验证Nrf2在氢气治疗中的作用。
处置流程与药物剂量
- 氢气治疗组:吸入2%氢气60分钟。
- 假手术组和CLP组:分别吸入空气1小时和6小时。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 主要终点:WT小鼠CLP+H2组7天生存率显著高于CLP组(45% vs 0%,P<0.05);Nrf2-KO小鼠两组均为0%(P>0.05)。
- 次要终点:WT小鼠CLP+H2组腹腔灌洗液CFU显著低于CLP组(×10³:34.7±6.3 vs 74.2±8.1,P<0.01);Nrf2-KO小鼠无显著差异(×10³:73.3±7.5 vs 75.8±8.6,P>0.05)。
- 机制指标:WT小鼠CLP+H2组肠组织HO-1蛋白表达显著高于CLP组(HO-1/β-actin:0.716±0.035 vs 0.460±0.045,P<0.01),HMGB1蛋白表达显著低于CLP组(HMGB1/β-actin:0.052±0.038 vs 0.082±0.008,P<0.01);Nrf2-KO小鼠上述指标无显著差异(P>0.05)。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型)。
- 证据等级或推荐强度:原文未提及。
- 局限:动物实验,样本为小鼠,结果不能直接外推至临床患者;Nrf2-KO小鼠为基因敲除模型,与人类病理生理存在差异。
对床旁实践的改变
- 该研究为动物实验,不能直接改变急诊或ICU对脓毒症患者的临床实践。
- 2%氢气吸入60分钟为实验性干预方案,尚未在临床脓毒症患者中验证安全性和有效性,不能作为临床推荐。
- Nrf2通路可能是氢气减轻脓毒症肠损伤的关键机制,但需进一步临床研究验证。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the protective effect of the hydrogen (H2) inhalation on intestinal injury in severe sepsis mice and its relationship with nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1)/high mobility group protein B1 (HMGB1) pathway.
METHODS: The 280 male wild-type (WT) and Nrf2 knockout (Nrf2-KO) ICR mice (6-8 weeks old, 20-25 g weight) were assigned into 8 groups randomly (WT and Nrf2-KO mice, 4 groups respectively, n = 35): Sham group, H2 inhalation group (Sham+H2 group), sepsis model group which was induced by cecal ligation and puncture (CLP group) and H2 treatment group (CLP+H2 group). In Sham group, except cecal ligation and perforation, the same surgery was used. The mice in Sham group and CLP group inhaled only air for 1 hour and 6 hours, respectively, while the mice in Sham+H2 group and CLP+H2 group inhaled 2% H2 for 60 minutes. After modeling, 20 mice randomly in each group were selected to measure 7-day natural survival rates; the remaining mice(15 mice) were killed in 24 hours after modeling, and the bacterial load was determined by collecting the peritoneal lavage fluid (PLF) of each mouse to measure the colony forming unit (CFU); and the intestinal tissue was taken after perfusion, and the intestinal tissue of 3 mice was used to extract protein for HO-1 and HMGB1 levels by using Western blotting. Intestinal tissue of 3 mice was extracted to prepare histomorphology sections for the identification of HO-1. Intestinal tissue of 3 mice was used to detect the expression of HMGB1 by immunofluorescence.
RESULTS: The 7-day survival rate of WT and Nrf2-KO mice in CLP group was zero; in WT mice, the 7-day survival rate of CLP+H2 group was significantly higher than that of CLP group (45% vs. 0%, P < 0.05), while no difference of the 7-day survival rate in Nrf2-KO mice was noted between CLP and CLP+H2 groups (0% vs. 0%, P > 0.05). Compared with Sham group, the CFU in the PLF of both mice in CLP group increased significantly. Compared with CLP group, 2% H2 treatment could significantly improve the bacterial clearance rate of WT mice with severe sepsis (CFU, ×103: 34.7±6.3 vs. 74.2±8.1, P < 0.01), but had no significant effect on Nrf2-KO mice with severe sepsis (CFU, ×103: 73.3±7.5 vs. 75.8±8.6, P > 0.05). The results of Western blotting, immunohistochemical and immune-fluorescence showed that the expression of HO-1 and HMGB1 in the CLP group were higher than those in the Sham group. Compared with CLP group, the expression of HO-1 in WT mice of CLP+H2 group was significantly higher [HO-1 protein expression (HO-1/β-actin): 0.716±0.035 vs. 0.460±0.045, HO-1 positive expression (A value): 0.703±0.135 vs. 0.430±0.116, both P < 0.01], while the expression of HMGB1 was significantly lower [HMGB1 protein expression (HMGB1/β-actin): 0.052±0.038 vs. 0.082±0.008, HMGB1 positive expression (A value): 24.530±9.317 vs. 41.830±2.458, both P < 0.01]. In Nrf2-KO mice, compared with CLP group, there was no statistical difference in the above indexes in CLP+H2 group [HO-1 protein expression (HO-1/β-actin): 0.148±0.004 vs. 0.164±0.043, HO-1 positive expression (A value): 0.109±0.020 vs. 0.113±0.025, HMGB1 protein expression (HMGB1/β-actin): 0.109±0.020 vs. 0.113±0.025, HMGB1 positive expression (A value): 39.570±12.660 vs. 42.790±9.680, all P > 0.05].
CONCLUSIONS: H2 can inhibit the intestinal injury of mice with severe sepsis through Nrf2/HO-1/HMGB1 pathway, and Nrf2 plays an important role in the treatment of intestinal injury with H2.
参考来源
- Yin L, Yang M, Yu Y, et al. [Hydrogen plays a protective role in intestinal injury of mice with severe sepsis by regulating the release of heme oxygenase-1 and high mobility group protein B1]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463500. doi:10.3760/cma.j.cn121430-20200717-00533
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。